Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.

The objective of this study is to construct complex of DNA and PLGA/HAp composite scaffold for bone tissue engineering. Naked DNA has low transfection efficiency so DNA loaded chitosan particles are used nowadays in gene delivery due to their high transfection efficiency, but unfortunately this is accompanied by strong immunological reaction of cells. In order to preserve the advantage of polymeric particles and reduce immunological effect at the same time, a new DNA release system is developed which makes possible sustained DNA release with negligible immunological effects. Poly (lactide-co-glycolide) (PLGA)/Hydroxylapatite (HAp) composite scaffolds with different HAp contents (0%, 5% and 10%) are fabricated by an electrospinning method and DNA is incorporated into the scaffolds in 3 ways (i.e. naked DNA, encapsulation of DNA/chitosan nanoparticles into scaffolds after fiber fabrication by dripping, and encapsulation of DNA/chitosan nanoparticles into scaffold by mixing with PLGA/HAp solution before fiber fabrication). All the scaffolds are characterized by SEM, XRD, DSC and GC-MS and the results show that the scaffolds are non-woven, nano- to micro-fibered membrane structures composed predominantly of PLGA with amorphous dispersion of HAp nanoparticles inside polymeric matrix. In vitro release tests were carried out on 9 different scaffolds to check the effects of HAp contents and the encapsulation ways of DNA on the release properties. These effects are also tested by human marrow stem cells (hMSCs) by comparing their cell attachment ability, cell viability and DNA transfection efficiency. It is demonstrated that the addition of HAp nanoparticles increased the release rate of DNA for both naked and encapsulated DNA. Cell culture experiments show that the scaffolds with encapsulated DNA/chitosan nanoparticles have higher cell attachment, higher cell viablility and desirable transfection efficiency of DNA. The observations show that DNA/chitosan nanoparticles encapsulated PLGA/HAp composite scaffold is promising for use in bone regeneration.

[1]  Krishnendu Roy,et al.  Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.

[2]  K. Kusumoto,et al.  Prefabricated muscle flap including bone induced by recombinant human bone morphogenetic protein-2: an experimental study of ectopic osteoinduction in a rat latissimus dorsi muscle flap. , 1998, British journal of plastic surgery.

[3]  Timothy E. Long,et al.  Electrospinning of linear homopolymers of poly(methyl methacrylate): exploring relationships between fiber formation, viscosity, molecular weight and concentration in a good solvent , 2005 .

[4]  Yasuhiko Tabata,et al.  Enhanced ectopic bone formation using a combination of plasmid DNA impregnation into 3-D scaffold and bioreactor perfusion culture. , 2006, Biomaterials.

[5]  P. Boyne,et al.  Application of Bone Morphogenetic Proteins in the Treatment of Clinical Oral and Maxillofacial Osseous Defects , 2001, The Journal of bone and joint surgery. American volume.

[6]  K. Takaoka,et al.  Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins. , 2005, Advanced drug delivery reviews.

[7]  R. Müller,et al.  Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy , 2001, The journal of gene medicine.

[8]  K. Leong,et al.  DNA-polycation nanospheres as non-viral gene delivery vehicles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[9]  M. Heidaran,et al.  Molecular Signaling in Bioengineered Tissue Microenvironments , 2002, Annals of the New York Academy of Sciences.

[10]  J. Lou,et al.  Gene therapy: Adenovirus‐mediated human bone morphogenetic protein‐2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[11]  R. Mumper,et al.  Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[12]  A Daluiski,et al.  The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. , 1999, The Journal of bone and joint surgery. American volume.

[13]  Y Wang,et al.  Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[14]  K. Kusumoto,et al.  Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2. , 1995, Biochemical and biophysical research communications.

[15]  David L Kaplan,et al.  Electrospun silk-BMP-2 scaffolds for bone tissue engineering. , 2006, Biomaterials.

[16]  Chi-Hwa Wang,et al.  Self-Assembled Biodegradable Nanoparticles Developed by Direct Dialysis for the Delivery of Paclitaxel , 2005, Pharmaceutical Research.

[17]  K. Leong,et al.  DNA-Chitosan nanospheres for gene delivery , 1996 .

[18]  Luigi Lazzeri,et al.  Biodegradable hollow microfibres to produce bioactive scaffolds , 2005 .

[19]  K. Kusumoto,et al.  Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites. , 2000, International journal of oral and maxillofacial surgery.